Hepatitis C Opportunities Light Up Infectious Disease Partnering Landscape
Executive Summary
"Without question, hepatitis C is the number one exciting area in infectious diseases," insists Paul Zhang, a principal in the health care advisory group Easton Associates, LLC.
You may also be interested in...
Achillion Aiming For Best-In-Class Protease Inhibitor, Working On Home-Grown Hep C Cocktail
While hepatitis C drug developers ponder the safety and tolerability issues likely to arise when direct-acting antivirals are combined in cocktails against the virus, Achillion Pharmaceuticals, Inc., a small company in New Haven, CT, is working on a portfolio of candidates it says not only combine safely, they work better in combination.
Achillion Aiming For Best-In-Class Protease Inhibitor, Working On Home-Grown Hep C Cocktail
While hepatitis C drug developers ponder the safety and tolerability issues likely to arise when direct-acting antivirals are combined in cocktails against the virus, Achillion Pharmaceuticals, Inc., a small company in New Haven, CT, is working on a portfolio of candidates it says not only combine safely, they work better in combination.
Infectious Diseases Space Wide Open For Partnering Beyond Hep C, Conference Finds
The recent spotlight on hepatitis C doesn't mean that's the only hot area in infectious diseases for deals.